BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Johnson & Johnson’s Dividend Legacy and Future Prospects
Johnson & Johnson’s Dividend Legacy and Future Prospects
19
2
BTCCSquare news:
Johnson & Johnson (JNJ) stands as a paragon of dividend reliability, having raised its payout for 63 consecutive years. This healthcare titan now focuses solely on pharmaceuticals and medical technology after spinning off its consumer health division. With 26 products each generating over $1 billion in annual sales, J&J's cash FLOW fuels both innovation and shareholder returns.
The company allocated $17 billion to R&D in 2024 while distributing $11.8 billion in dividends. Its ambition to dominate oncology with $50 billion in sales underscores the growth potential supporting future dividend hikes. Such financial discipline cements J&J's status among the elite Dividend Kings.
By:
